Revenue
2018
2019
2020
2021
2022
2023
2024
2025
COLGATE PALMOLIVE CO (CL)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.38B | $20.10B | $19.46B | $17.97B | $17.42B | $16.47B | $15.69B | $15.54B | $15.45B | $15.20B | $16.03B | $17.28B | $17.42B | $17.09B | $16.73B | $15.56B | $15.33B | $15.33B | $13.79B |
| Gross profit | $12.25B | $12.16B | $11.33B | $10.25B | $10.38B | $10.02B | $9.32B | $9.23B | $9.28B | $9.12B | $9.40B | $10.11B | $10.20B | $9.93B | $9.59B | $9.20B | $9.01B | $8.63B | $7.75B |
| Research & development | $366.0M | $355.0M | $343.0M | $320.0M | $307.0M | $290.0M | $281.0M | $277.0M | $285.0M | $289.0M | $274.0M | $277.0M | $267.0M | $259.0M | $262.0M | $256.0M | $256.0M | $240.0M | — |
| Operating income | $3.31B | $4.27B | $3.98B | $2.89B | $3.33B | $3.88B | $3.55B | $3.69B | $3.71B | $3.96B | $2.79B | $3.56B | $3.56B | $3.89B | $3.84B | $3.49B | $3.62B | $3.10B | $2.72B |
| EBITDAderived | $3.94B | $4.87B | $4.55B | $3.44B | $3.89B | $4.42B | $4.07B | $4.21B | $4.18B | $4.40B | $3.24B | $4.00B | $4.00B | $4.31B | $4.26B | $3.87B | $3.97B | $3.45B | $3.05B |
| Net income | $2.13B | $2.89B | $2.30B | $1.78B | $2.17B | $2.69B | $2.37B | $2.40B | $2.02B | $2.44B | $1.38B | $2.18B | $2.24B | $2.47B | $2.43B | $2.20B | $2.29B | $1.96B | $1.74B |
| Basic EPSper diluted share | $2.64 | $3.53 | $2.78 | $2.13 | $2.56 | $3.15 | $2.76 | $2.76 | $2.30 | $2.74 | $1.53 | $2.38 | $2.41 | $2.60 | $2.49 | $4.45 | $4.53 | $3.81 | $3.35 |
| Diluted EPSper diluted share | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 | $3.14 | $2.75 | $2.75 | $2.28 | $2.72 | $1.52 | $2.36 | $2.38 | $2.57 | $2.47 | $4.31 | $4.37 | $3.66 | $3.20 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 15, 2026Form 4 | Malcolm GregoryEVP and Controller | SellCommon Stock | 2.3K | $88.44 | $203.4K | 13.6K |
| May 7, 2026Form 4 | Massey SallyChief People Officer | SellCommon Stock | 8.6K | $87.41 | $751.6K | 13.8K |
| Feb 12, 2026Form 4 | Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, Skin | SellCommon Stock | 15.0K | $97.81 | $1.47M | 10.4K |
| Feb 11, 2026Form 4 | Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, Skin | SellCommon Stock | 35.0K | $94.61 | $3.31M | 10.4K |
| Feb 10, 2026Form 4 | Hazlin JohnChief Growth Officer | SellCommon Stock | 21.0K | $94.25 | $1.98M | 17.6K |